Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Kyung Nam Pharm Co., Ltd. (053950:KRX), powered by AI.
Kyung Nam Pharm Co., Ltd. is currently trading at ₩2,015. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Kyung Nam Pharm Co., Ltd. on Alpha Lenz.
Kyung Nam Pharm Co., Ltd.'s P/E ratio is -3.5.
“Kyung Nam Pharm Co., Ltd. trades at a P/E of -3.5 (undervalued) with modest ROE of -8.1%.”
Ask for details →Kyung Nam Pharm Co., Ltd. is a distinguished pharmaceutical company engaged in the manufacture and distribution of a broad array of healthcare products. Its primary function is to develop therapeutic solutions that cater to a wide range of medical needs, including pain management, cardiovascular health, and gastrointestinal wellbeing. The company plays a significant role in the healthcare sector, not only through its production of high-quality pharmaceuticals but also via its active research and development initiatives aimed at innovating new drugs and health supplements. With facilities equipped to meet international safety and quality standards, Kyung Nam Pharm Co., Ltd. serves both domestic and global markets, reinforcing its position in the pharmaceutical industry. Its impact is substantial in promoting public health and advancing medical science, making it a notable player in supporting healthcare systems and contributing to broader wellness objectives.
“Kyung Nam Pharm Co., Ltd. trades at a P/E of -3.5 (undervalued) with modest ROE of -8.1%.”
Ask for details →Kyung Nam Pharm Co., Ltd. (ticker: 053950) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $31.5B.
The current price is ₩2,015 with a P/E ratio of -3.5x and P/B of 0.29x.
ROE is -8.06% and operating margin is -3.10%. Annual revenue is $55.9B.